Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Baruchel

Showing results (211-220 of 590) with videos related to

Pageof 59
Sort By:
Cancer Detection and Prevention|November 18, 2005
Maternal coffee and alcohol consumption during pregnancy, parental smoking and risk of childhood acute leukaemiaFlorence Menegaux, Christoph Steffen, Stéphanie Bellec, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 24, 2003
Family history of autoimmune thyroid disease and childhood acute leukemiaFlorence Perillat-Menegaux, Jacqueline Clavel, Marie-Françoise Auclerc, et al.
European Journal of Pediatrics|May 17, 2002
Breast-feeding, fetal loss and childhood acute leukaemiaFlorence Perrillat, Jacqueline Clavel, Isabelle Jaussent, et al.
European Journal of Cancer (Oxford, England : 1990)|November 18, 2011
A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhabdomyosarcoma soft tissue sarcomas: a report from the Children's Oncology GroupSylvain Baruchel, Alberto Pappo, Mark Krailo, et al.
Journal of Pediatric Hematology/Oncology|December 22, 1999
Phase I and pharmacokinetic study of CI-980 in recurrent pediatric solid tumor cases: a Pediatric Oncology Group studyM L Bernstein, S Baruchel, S Devine, et al.
Investigational New Drugs|January 1, 1995
A phase I study of acivicin in refractory pediatric solid tumors. A Pediatric Oncology Group studyS Baruchel, M Bernstein, V M Whitehead, et al.
Journal of Clinical Medicine|March 29, 2023
The Development of New Agents for Post-Hematopoietic Stem Cell Transplantation Non-Infectious Complications in ChildrenUri Ilan, Erica Brivio, Mattia Algeri, et al.
Bone Marrow Transplantation|July 1, 1997
Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de MoëlleP Brice, R Bouabdallah, P Moreau, et al.
Frontiers in Oncology|March 15, 2021
Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a <i>KMT2A</i>-Rearranged LeukemiaBenoît Brethon, Elodie Lainey, Aurélie Caye-Eude, et al.
Hemasphere|June 1, 2023
Real-world Experience of Approved Chimeric Antigen Receptor T-cell Therapies Compared to Clinical Trials DataJérôme Lambert, Roberta Di Blasi, Florence Rabian, et al.
Pageof 59

Showing results (211-220 of 590) with videos related to

Sort By:
Pageof 59
Cancer Detection and Prevention|November 18, 2005
Maternal coffee and alcohol consumption during pregnancy, parental smoking and risk of childhood acute leukaemiaFlorence Menegaux, Christoph Steffen, Stéphanie Bellec, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 24, 2003
Family history of autoimmune thyroid disease and childhood acute leukemiaFlorence Perillat-Menegaux, Jacqueline Clavel, Marie-Françoise Auclerc, et al.
European Journal of Pediatrics|May 17, 2002
Breast-feeding, fetal loss and childhood acute leukaemiaFlorence Perrillat, Jacqueline Clavel, Isabelle Jaussent, et al.
European Journal of Cancer (Oxford, England : 1990)|November 18, 2011
A phase 2 trial of trabectedin in children with recurrent rhabdomyosarcoma, Ewing sarcoma and non-rhabdomyosarcoma soft tissue sarcomas: a report from the Children's Oncology GroupSylvain Baruchel, Alberto Pappo, Mark Krailo, et al.
Journal of Pediatric Hematology/Oncology|December 22, 1999
Phase I and pharmacokinetic study of CI-980 in recurrent pediatric solid tumor cases: a Pediatric Oncology Group studyM L Bernstein, S Baruchel, S Devine, et al.
Investigational New Drugs|January 1, 1995
A phase I study of acivicin in refractory pediatric solid tumors. A Pediatric Oncology Group studyS Baruchel, M Bernstein, V M Whitehead, et al.
Journal of Clinical Medicine|March 29, 2023
The Development of New Agents for Post-Hematopoietic Stem Cell Transplantation Non-Infectious Complications in ChildrenUri Ilan, Erica Brivio, Mattia Algeri, et al.
Bone Marrow Transplantation|July 1, 1997
Prognostic factors for survival after high-dose therapy and autologous stem cell transplantation for patients with relapsing Hodgkin's disease: analysis of 280 patients from the French registry. Société Française de Greffe de MoëlleP Brice, R Bouabdallah, P Moreau, et al.
Frontiers in Oncology|March 15, 2021
Case Report: Targeting 2 Antigens as a Promising Strategy in Mixed Phenotype Acute Leukemia: Combination of Blinatumomab With Gemtuzumab Ozogamicin in an Infant With a <i>KMT2A</i>-Rearranged LeukemiaBenoît Brethon, Elodie Lainey, Aurélie Caye-Eude, et al.
Hemasphere|June 1, 2023
Real-world Experience of Approved Chimeric Antigen Receptor T-cell Therapies Compared to Clinical Trials DataJérôme Lambert, Roberta Di Blasi, Florence Rabian, et al.
Pageof 59